Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Daptomycin for highly resistant Enterococcus faecium infection.

Rosin C, Bernsmeier C, Entenza JM, Moreillon P, Frei R, Weisser M, Fl├╝ckiger U.

Swiss Med Wkly. 2012 Jun 26;142:w13603. doi: 10.4414/smw.2012.13603.

2.

Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.

Lewis JS 2nd, Owens A, Cadena J, Sabol K, Patterson JE, Jorgensen JH.

Antimicrob Agents Chemother. 2005 Apr;49(4):1664-5. No abstract available. Erratum in: Antimicrob Agents Chemother. 2005 May;49(5):2152.

3.

Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.

Schutt AC, Bohm NM.

Ann Pharmacother. 2009 Dec;43(12):2108-12. doi: 10.1345/aph.1M324. Epub 2009 Nov 3.

PMID:
19887592
4.
5.

Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.

Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA.

Antimicrob Agents Chemother. 2012 Feb;56(2):838-44. doi: 10.1128/AAC.05551-11. Epub 2011 Nov 28.

6.

Emergence of daptomycin-resistant VRE: experience of a single institution.

Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA.

Infect Control Hosp Epidemiol. 2011 Apr;32(4):391-4. doi: 10.1086/659152.

7.

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).

Mohr JF, Friedrich LV, Yankelev S, Lamp KC.

Int J Antimicrob Agents. 2009 Jun;33(6):543-8. doi: 10.1016/j.ijantimicag.2008.12.007. Epub 2009 Feb 6.

PMID:
19201165
8.

Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.

Kvirikadze N, Suseno M, Vescio T, Kaminer L, Singh K.

Scand J Infect Dis. 2006;38(4):290-2.

PMID:
16709529
9.

Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.

Tascini C, Di Paolo A, Polillo M, Ferrari M, Lambelet P, Danesi R, Menichetti F.

Antimicrob Agents Chemother. 2011 May;55(5):2458-9. doi: 10.1128/AAC.01774-10. Epub 2011 Feb 22.

10.

Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.

Vouillamoz J, Moreillon P, Giddey M, Entenza JM.

J Antimicrob Chemother. 2006 Dec;58(6):1208-14. Epub 2006 Oct 9.

11.

Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection.

Alder J, Li T, Yu D, Morton L, Silverman J, Zhang XX, Critchley I, Thorne G.

Antimicrob Agents Chemother. 2003 Nov;47(11):3561-6.

12.

Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.

Knoll BM, Hellmann M, Kotton CN.

Scand J Infect Dis. 2013 Feb;45(2):131-9. doi: 10.3109/00365548.2012.717711. Epub 2012 Sep 19.

PMID:
22992165
13.
15.
16.

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.

Munita JM, Mishra NN, Alvarez D, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Adachi JA, Bayer AS, Arias CA.

Clin Infect Dis. 2014 Nov 1;59(9):1277-80. doi: 10.1093/cid/ciu642. Epub 2014 Aug 8.

17.

Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.

Fraher MH, Corcoran GD, Creagh S, Feeney E.

J Hosp Infect. 2007 Apr;65(4):376-8. Epub 2007 Feb 20. No abstract available.

PMID:
17316896
18.

Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.

Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP.

Antimicrob Agents Chemother. 1994 Jun;38(6):1363-7.

19.

Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.

Noskin GA, Siddiqui F, Stosor V, Kruzynski J, Peterson LR.

Clin Infect Dis. 1999 Mar;28(3):689-90. No abstract available.

20.

De novo daptomycin nonsusceptibility in a clinical isolate.

Lesho EP, Wortmann GW, Craft D, Moran KA.

J Clin Microbiol. 2006 Feb;44(2):673. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk